Stock Fundamentals

Company Information

▼
Company Name
OUTLOOK THERAPEUTICS INC
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
ISIN: US69012T3059
CIK: 0001649989
CUSIP: 68235M204
Currency: USD
Full Time Employees: 17
Phone: 609 619 3990
Website: https://outlooktherapeutics.com
Fiscal Year End: September
IPO Date: May 13, 2016
Description:

Outlook Therapeutics, Inc., operates as a clinical-stage biopharmaceutical company, focuses on developing and commercializing monoclonal antibodies for ophthalmic indications. Its lead product candidate is ONS-5010, an ophthalmic bevacizumab product formulation of bevacizumab product candidate that is in Phase-III clinical trial for the treatment of wet age-related macular degeneration and other retina diseases. Outlook Therapeutics, Inc. has collaboration agreements with Cencora. Outlook Therapeutics, Inc. was formerly known as Oncobiologics, Inc. and changed its name to Outlook Therapeutics, Inc. in November 2018. Outlook Therapeutics, Inc. was incorporated in 2010 and is based in Iselin, New Jersey.

Address:

111 S. Wood Avenue, Iselin, NJ, United States, 08830

Directors & Officers

▼
Name Title Year Born
Mr. Robert Charles Jahr President, CEO & Director 1973
Mr. Lawrence A. Kenyon CPA EVP, CFO, Treasurer, Secretary & Director 1966
Mr. Joel Prieve Senior Vice President of Licensing and M&A NA
Dr. Surendra Sharma M.D. Senior Vice President of Medical Affairs NA
Dr. Jennifer M. Kissner Ph.D. Senior Vice President of Clinical Development & Regulatory Affairs NA
Mr. Jedd Comiskey Senior VP - Head of Europe NA

Institutional Holders

▼
Holder Name Shares Date Reported % Out Value % Change
Schonfeld Strategic Advisors LLC 2.44M Dec 31, 2025 2.94% $0.02 241.37%
Vanguard Group Inc 1.47M Dec 31, 2025 1.76% $0.00 9.13%
BlackRock Inc 369.73K Sep 30, 2025 0.45% $0.00 8.78%
Geode Capital Management, LLC 306.30K Sep 30, 2025 0.37% $0.00 15.31%
Susquehanna International Group, LLP 211.42K Sep 30, 2025 0.25% $0.00 79.52%
Millennium Management LLC 194.58K Sep 30, 2025 0.23% $0.00 -42.53%
Commonwealth Equity Services Inc 113.15K Sep 30, 2025 0.14% $0.00 301.94%
Bank of America Corp 90.48K Sep 30, 2025 0.11% $0.00 1,058.01%
SIMPLEX TRADING, LLC 89.24K Sep 30, 2025 0.11% $0.00 0.00%
State Street Corp 75.30K Sep 30, 2025 0.09% $0.00 -11.88%
Scotia Capital Inc 73.99K Sep 30, 2025 0.09% $0.00 0.00%
LVW Advisors, LLC 48.24K Dec 31, 2025 0.06% $0.01 0.00%
UBS Group AG 48.11K Sep 30, 2025 0.06% $0.00 -12.72%
The Goldman Sachs Group Inc 42.97K Sep 30, 2025 0.05% $0.00 -53.48%
Vontobel Holding Ltd. 40.00K Dec 31, 2025 0.05% $0.00 0.00%
TWO SIGMA SECURITIES, LLC 35.66K Sep 30, 2025 0.04% $0.01 0.00%
LPL Financial Corp 28.42K Sep 30, 2025 0.03% $0.00 87.90%
Christensen King & Associates Investment Services Inc 28.33K Dec 31, 2025 0.03% $0.02 4.11%
Northern Trust Corp 26.07K Sep 30, 2025 0.03% $0.00 -33.15%
Jane Street Group LLC 25.83K Sep 30, 2025 0.03% $0.00 -63.53%

Shares Statistics

▼
Shares Outstanding: 73.51M
Shares Float: 67.73M
% Insiders: 1,845.30%
% Institutions: 822.40%
Short % Float: 6.12%

🏆 Top 10 Institutional Holders

▼
Rank Holder Name Shares Held % of Shares Change Date Reported
1 Schonfeld Strategic Advisors LLC 2.44M 2.94% ▲ 241.37% Dec 31, 2025
2 Vanguard Group Inc 1.47M 1.76% ▲ 9.13% Dec 31, 2025
3 BlackRock Inc 369.73K 0.45% ▲ 8.78% Sep 30, 2025
4 Geode Capital Management, LLC 306.30K 0.37% ▲ 15.31% Sep 30, 2025
5 Susquehanna International Group, LLP 211.42K 0.25% ▲ 79.52% Sep 30, 2025
6 Millennium Management LLC 194.58K 0.23% ▼ 42.53% Sep 30, 2025
7 Commonwealth Equity Services Inc 113.15K 0.14% ▲ 301.94% Sep 30, 2025
8 Bank of America Corp 90.48K 0.11% ▲ 1,058.01% Sep 30, 2025
9 SIMPLEX TRADING, LLC 89.24K 0.11% ▲ 0.00% Sep 30, 2025
10 State Street Corp 75.30K 0.09% ▼ 11.88% Sep 30, 2025

Valuation Metrics

▼
Enterprise Value: $53.44M
Trailing P/E: 0.00
Forward P/E: 2.85

Financial Highlights

▼
Market Cap: $30.93M
EBITDA: $-58.82M
Book Value: $-0.60
Earnings/Share: $-2.89
Profit Margin: 0.00%
Operating Margin: 1,116.38%
ROA (TTM): -209.04%
ROE (TTM): -3.65%
Revenue (TTM): $205.70K
Revenue/Share (TTM): $0.01
Earnings Growth (YOY): 0.00%
Revenue Growth (YOY): 658.30%

Stock Price History

▼

1 Year Price History

2 Years Price History

5 Years Price History

10 Years Price History

Download Financials (Excel)

Financial Charts

▼

Revenue & Net Income (Yearly)

Revenue & Net Income (Quarterly)

Operating Expenses (Yearly)

Operating Expenses (Quarterly)

Balance Sheet (Yearly)

Balance Sheet (Quarterly)

Assets Breakdown (Yearly)

Assets Breakdown (Quarterly)

Liabilities Breakdown (Yearly)

Liabilities Breakdown (Quarterly)

Earnings Per Share (EPS) History

▼

Financial Ratios (Yearly)

▼

Financial Ratios (Quarterly)

▼

Earnings History

▼

Balance Sheet (Yearly)

▼

Financial Ratios

▼
Date Current Ratio Debt/Equity Debt/Assets Interest Coverage Debt/EBITDA
2025-09-30 0.38x 0.00x 2.73x -236.86x -926.40x
2024-09-30 0.64x -0.40x 3.54x -22.71x -0.41x
2023-09-30 0.66x -2.46x 1.45x -34.06x -0.62x
2022-09-30 1.39x 1.25x 0.69x -42.41x -0.17x
2021-09-30 3.19x 2.57x 0.80x -55.26x -0.23x
2020-09-30 1.13x 3.10x 0.86x -20.98x -0.24x
2019-09-30 0.67x -1.08x 1.63x -10.47x -0.37x
2018-09-30 0.10x -0.89x 1.93x -7.62x -0.69x
2017-09-30 0.14x -0.60x 2.48x -6.38x -0.61x
2016-09-30 0.28x -1.62x 1.22x -27.73x -0.17x
2015-09-30 0.16x -0.70x 3.03x -20.27x -0.37x
2014-09-30 0.41x -0.68x 1.84x -13.75x -1.69x

Insider Trading

Date Insider Name Title Transaction Type Shares Price Value
Sep 26, 2024 Lawrence A Kenyon N/A Purchase 5.00K $5.69 $28.45K
Mar 28, 2024 Yezan Munther Haddadin N/A Purchase 1.88K $11.82 $22.25K
Apr 20, 2023 Terry Dagnon N/A Sale 26.00K $22.80 $592.80K

📦 Raw API Data (JSON Explorer)

▼

Watchlist

0

No stocks in watchlist

Assistant

×
Hello! I'm your AI assistant. I have access to the financial data on this page. Ask me anything about OTLK.US!